Prognostic significance of p53 mutation in breast cancer: Frequent detection of non-missense mutations by yeast functional assay

International Journal of Cancer

Volumn 84, Issue 6, 1999, Pages 587-593

  Chappuis, Pierre O ^a,d   Estreicher, Anne ^b   Dieterich, Barbara ^c   Bonnefoi, Hervé ^a   Otter, Michèle ^b   Sappino, André Pascal ^a   Iggo, Richard ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BIOASSAY; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; FEMALE; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MISSENSE MUTATION; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENES, FUNGAL; GENES, P53; HUMANS; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; SURVIVAL RATE; YEASTS;

EID: 0032785881     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991222)84:6<587::AID-IJC8>3.0.CO;2-8     Document Type: Article

References (21)

1. DIETERICH, B., ALBE, X., VASSILAKOS, P., WIESER, S., FRIEDRICH, R. and KRAUER, F., The prognostic value of DNA ploidy and S-phase estimate in primary breast cancer: a prospective study. Int. J. Cancer, 63, 49-54 (1995).
2. ELLIS, P.A., LONNING, P.E., BØRRESEN-DALE, A., AAS, T., GEISLER, S., AKSLEN, L.A., SALTER, I., SMITH, I.E. and DOWSETT, M., Absence of p21 expression is associated with abnormal p53 in human breast carcinomas. Brit. J. Cancer, 76, 480-485 (1997).
3. FISHER, B., REDMOND, C., DIMITROV, N.V., BOWMAN, D., LEGAULT-POISSON, S., WICKERHAM, D.L., WOLMARK, N., FISHER, E.R., MARGOLESE, R. and SUTHERLAND, C., A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N. Engl. J. Med., 320, 473-478 (1989).
4. FLAMAN, J.M. and 13 OTHERS, A simple p53 functional assay for screening cell lines, blood, and tumors. Proc. nat. Acad. Sci. (Wash.), 92, 3963-3967 (1995).
5. FLAMAN, J.M., ROBERT, V., LENGLET, S., MOREAU, V., IGGO, R. and FREBOURG, T., Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast. Oncogene, 16, 1369-1372 (1998).
6. FLAMAN, J.M., WARIDEL, F., ESTREICHER, A., VANNIER, A., LIMACHER, J.M., GILBERT, D., IGGO, R. and FREBOURG, T., The human tumour suppressor gene p53 is alternatively spliced in normal cells. Oncogene, 12, 813-818 (1996).
7. HAINAUT, P., HERNANDEZ, T., ROBINSON, A., RODRIGUEZ-TOME, P., FLORES, T., HOLLSTEIN, M., HARRIS, C.C. and MONTESANO, R., IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucl. Acids Res., 26, 205-213 (1998).
8. HARTMANN, A., BLASZYK, H., KOVACH, J.S. and SOMMER, S.S., The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet., 13, 27-33 (1997).
9. HENSON, D.E., RIES, L., FREEDMAN, L.S. and CARRIAGA, M., Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer, 68, 2142-2149 (1991).
10. KOVACH, J.S., HARTMANN, A., BLASZYK, H., CUNNINGHAM, J., SCHAID, D. and SOMMER, S.S., Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc. nat. Acad. Sci. (Wash.), 93, 1093-1096 (1996).
11. LELLE, R.J., HEIDENREICH, W., STAUCH, G. and GERDES, J., The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma. Cancer, 59, 83-88 (1987).
12. LOMAX, M.E., BARNES, D.M., GILCHRIST, R., PICKSLEY, S.M., VARLEY, J.M. and CAMPLEJOHN, R.S., Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family. Oncogene, 14, 1869-1874 (1997).
13. LOWE, S.W., BODIS, S., MCCLATCHEY, A., REMINGTON, L., RULEY, H.E., FISHER, D.E., HOUSMAN, D.E. and JACKS, T., p53 status and the efficacy of cancer therapy in vivo. Science, 266, 807-810 (1994).
14. MACLEOD, K.F., SHERRY, N., HANNON, G., BEACH, D., TOKINO, T., KINZLER, K., VOGELSTEIN, B. and JACKS, T., p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9, 935-944 (1995).
15. MANSOUR, E.G., GRAY, R., SHATILA, A.H., OSBORNE, C.K., TORMEY, D.C., GILCHRIST, K.W., COOPER, M.R. and FALKSON, G., Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N. Engl. J. Med., 320, 485-490 (1989).
16. PINDER, S.E. and 14 OTHERS, The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer, 83, 1529-1539 (1998).
17. SJÖGREN, S., INGANAS, M., NORBERG, T., LINDGREN, A., NORDGREN, H., HOLMBERG, L. and BERGH, J., The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J. nat. Cancer Inst., 88, 173-182 (1996).
18. SOUSSI, T., The p53 tumour suppressor gene: from molecular biology to clinical investigation. In: J.G.M. Klijn (ed.). Prognostic and predictive value of p53, ESO scientific updates, Vol. 1, pp. 3-21, Elsevier, Amsterdam (1997).
19. TADA, M., MATSUMOTO, R., IGGO, R.D., ONIMARU, R., SHIRATO, H., SAWAMURA, Y. and SHINOHE, Y., Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations. Cancer Res., 58, 1793-1797 (1998).
20. WARIDEL, F., ESTREICHER, A., BRON, L., FLAMAN, J.M., FONTOLLIET, C., MONNIER, P., FREBOURG, T. and IGGO, R., Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene, 14, 163-169 (1997).
21. WILLIAMS, C., NORBERG, T., AHMADIAN, A., PONTÉN, F., BERGH, J., INGANAS, M., LUNDEBERG, J. and UHLEN, M., Assessment of sequence-based p53 gene analysis in human breast cancer: messenger RNA in comparison with genomic DNA targets. Clin. Chem., 44, 455-462 (1998).